Table 2.
Patients’ characteristics according to drug adherence
| VARIABLE | Discontinuated patients | Adherent patients | Standardized difference (%) * |
|---|---|---|---|
| Mean age (± SD) | 70.15 (9.6) | 70.37 (9.34) | - |
| Age class | |||
| 40–55 | 762 (6.21) | 937 (5.86) | −1.4916 |
| 56–65 | 3131 (25.52) | 3870 (24.18) | −3.0886 |
| 66–75 | 4784 (38.99) | 6336 (39.59) | 1.2350 |
| 76–85 | 2936 (23.93) | 4118 (25.73) | 4.1775 |
| >85 | 657 (5.35) | 742 (4.64) | −3.2957 |
| Previous hospitalization for BPH | 560 (4.56) | 752 (4.70) | 0.6430 |
| Previous BPH surgery | 45 (0.37) | 53 (0.33) | −0.6030 |
| Previous BPH severity factors | 392 (3.19) | 462 (2.89) | −1.7928 |
| Previous BPH related therapy | 7155 (58.31) | 9336 (58.34) | 0.0529 |
| Therapeutic regimen | |||
| AB | 10923 (89.02) | 13703 (85.63) | −10.2158 |
| 5ARI | 1050 (8.56) | 1259 (7.87) | −2.5140 |
| CT | 297 (2.42) | 1041 (6.51) | 19.8785 |
Legend: AB: Alpha-blocker monotherapy; 5ARI; 5-alpha reductase inhibitors monotherapy; CT: Combination Therapy; * Standardized difference greater than 10 % represents meaningful imbalance in explored variable between treatment groups